Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination.
Improving drug delivery technology for treating neurodegenerative diseases.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors.
The neuroimaging of Leigh syndrome: case series and review of the literature.
Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review.
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis.
Multiple sclerosis rehabilitation.
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
NMO spectrum disorders: how wide is the spectrum?
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
Axonal Damage in Pediatric Multiple Sclerosis.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Estimated Prevalence and Incidence of Multiple Sclerosis in Iran.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS.
Demyelination preceding a diagnosis of central nervous system lymphoma.
Pages
« first
‹ previous
…
507
508
509
510
511
512
513
514
515
…
next ›
last »